RAINBOW - Investment Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Investment Rating: 4.4

📊 Long-Term Investment Analysis: Rainbow Children's Medicare Ltd (RAINBOW)

Rainbow is a high-growth healthcare stock with strong fundamentals and a niche focus on pediatric and maternity care. However, its valuation metrics suggest caution for new investors.

✅ Strengths

ROCE (18.7%) and ROE (17.4%): Excellent capital efficiency.

Consistent PAT Growth: ₹53.5 Cr vs ₹56.3 Cr previous quarter, with 35.3% YoY variation.

EPS Growth: ₹25.4, with strong historical CAGR in profits (~34% over 5 years).

Low Debt-to-Equity (0.52): Financially stable.

Strong Brand & Expansion: Largest pediatric hospital chain in India with 19 hospitals and 5 clinics.

3-Year Return: 215.16% vs Nifty 50’s 56.47%

1

.

⚠️ Concerns

High P/E (60.3) vs Industry PE (69.2): Premium valuation.

PEG Ratio of 3.03: Indicates overvaluation relative to growth.

Low Dividend Yield (0.20%): Not ideal for income investors.

Book Value (₹145) vs Price (₹1,525): High P/B ratio (~10.5), signals premium pricing.

🎯 Ideal Entry Price Zone

Based on valuation compression and technical support

Fair Value Estimate: ₹1,350–₹1,450

Ideal Entry Zone: ₹1,300–₹1,400

Near 200 DMA (₹1,421) and below recent high of ₹1,710

Offers margin of safety with upside potential toward ₹2,200–₹2,500 by FY27

🧭 Exit Strategy / Holding Period

If you already hold RAINBOW

📌 Holding Period

5–7 years, to benefit from hospital expansion, operating margin growth, and brand premium.

Long-term targets suggest potential price of ₹3,800–₹4,500 by 2030

🚪 Exit Strategy

Partial Exit: If price crosses ₹2,200–₹2,300 without ROE improving above 20%.

Full Exit: If PEG remains above 3 or PAT growth stagnates for 2+ quarters.

Stop Loss: ₹1,250 (strong technical support zone)

Monitor

Expansion into Tier 2 cities and international markets

Margin trends and occupancy rates

Government policy changes in healthcare sector

📉 Summary Table

Metric Value Verdict

P/E 60.3 Overvalued ⚠️

ROE 17.4% Strong ✅

ROCE 18.7% Excellent ✅

PEG Ratio 3.03 Unfavorable ⚠️

Dividend Yield 0.20% Low ⚠️

Debt-to-Equity 0.52 Stable ✅

Entry Price Zone ₹1,300–₹1,400 Value Buy ✅

Exit Price Trigger ₹2,200+ Profit Booking Zone ⚠️

Would you like a comparison with peers like Apollo Hospitals or KIMS, or a breakdown of Rainbow’s expansion strategy?

1

bing.com

Edit in a page